+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hospital Acquired Infection Control: Global Strategic Business Report

  • PDF Icon

    Report

  • 246 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5030036

Global Hospital Acquired Infection Control Market to Reach $32.4 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Hospital Acquired Infection Control estimated at US$28.6 Billion in the year 2020, is projected to reach a revised size of US$32.4 Billion by 2027, growing at a CAGR of 1.8% over the analysis period 2020-2027. Protective Barrier, one of the segments analyzed in the report, is projected to record a 1.6% CAGR and reach US$10.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Sterilization Equipment segment is readjusted to a revised 2% CAGR for the next 7-year period.

The U.S. Market is Estimated at $7.8 Billion, While China is Forecast to Grow at 2.8% CAGR

The Hospital Acquired Infection Control market in the U.S. is estimated at US$7.8 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$5.8 Billion by the year 2027 trailing a CAGR of 2.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.3% and 1.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4 Billion by the year 2027.

Disinfectants Segment to Record 2.5% CAGR

In the global Disinfectants segment, USA, Canada, Japan, China and Europe will drive the 2.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$4.3 Billion in the year 2020 will reach a projected size of US$5.1 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 2.6% CAGR through the analysis period.

Select Competitors (Total 46 Featured) -

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and a Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Hospital Acquired Infection Control

What is the estimated value of the Global Market for Hospital Acquired Infection Control?

The Global Market for Hospital Acquired Infection Control was estimated to be valued at $28.6 Billion in 2020.

What is the growth rate of the Global Market for Hospital Acquired Infection Control?

The growth rate of the Global Market for Hospital Acquired Infection Control is 1.8%, with an estimated value of $32.4 Billion by 2027.

What is the forecasted size of the Global Market for Hospital Acquired Infection Control?

The Global Market for Hospital Acquired Infection Control is estimated to be worth $32.4 Billion by 2027.

Who are the key companies in the Global Market for Hospital Acquired Infection Control?

Key companies in the Global Market for Hospital Acquired Infection Control include Advanced Sterilization Products, Alere, Inc., Bayer AG, Belimed AG, Cepheid, Inc., F. Hoffmann, La Roche AG, Getinge AB (Getinge Group) and Merck & Co., Inc..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Hospital Acquired Infection Control - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Hospital Acquired Infection Control Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
  • Table 8: World Recent Past, Current & Future Analysis for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 9: World Historic Review for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 10: World 15-Year Perspective for Protective Barrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 11: World Recent Past, Current & Future Analysis for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World Historic Review for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 13: World 15-Year Perspective for Sterilization Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 14: World Recent Past, Current & Future Analysis for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 15: World Historic Review for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 16: World 15-Year Perspective for Disinfectants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 17: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 19: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 20: World Recent Past, Current & Future Analysis for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 21: World Historic Review for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 22: World 15-Year Perspective for Hospitals & ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 23: World Recent Past, Current & Future Analysis for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 24: World Historic Review for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 25: World 15-Year Perspective for Ambulatory Surgery & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 26: World Recent Past, Current & Future Analysis for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 27: World Historic Review for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
  • Table 28: World 15-Year Perspective for Nursing Homes & Maternity Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Active Players in United States
CANADA
  • Active Players in Canada
JAPAN
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Active Players in Japan
CHINA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Active Players in China
EUROPE
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
FRANCE
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Active Players in France
GERMANY
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Active Players in Germany
ITALY
  • Active Players in Italy
UNITED KINGDOM
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Active Players in United Kingdom
SPAIN
  • Active Players in Spain
RUSSIA
  • Active Players in Russia
REST OF EUROPE
  • Active Players in Rest of Europe
ASIA-PACIFIC
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
AUSTRALIA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
  • Active Players in Australia
INDIA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
  • Active Players in India
SOUTH KOREA
  • Active Players in South Korea
REST OF ASIA-PACIFIC
  • Active Players in Rest of Asia-Pacific
LATIN AMERICA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINA
  • Active Players in Argentina
BRAZIL
  • Active Players in Brazil
MEXICO
  • Active Players in Mexico
REST OF LATIN AMERICA
  • Active Players in Rest of Latin America
MIDDLE EAST
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRAN
  • Active Players in Iran
ISRAEL
  • Active Players in Israel
SAUDI ARABIA
  • Active Players in Saudi Arabia
UNITED ARAB EMIRATES
  • Active Players in United Arab Emirates
REST OF MIDDLE EAST
  • Active Players in Rest of Middle East
AFRICA
  • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
  • Active Players in Africa
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC